Jarryd McGuire
Psychiatric/Mental Health · New Lenox, ILNPI 1154998342
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,408 and has fallen 76.4% since, to $569 in 2024. Among psychiatric/mental health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$779
- AbbVie$634
- Vanda Pharmaceuticals Inc.$414
- Neos Therapeutics, LP$407
- Otsuka America Pharmaceutical, Inc.$325
- Alkermes, Inc.$321
- plus $3K from 20 others
What the payments were for
- Food & beverage$5,40399%
- Education$541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 39 | $779 |
| AbbVie | 29 | $634 |
| Vanda Pharmaceuticals Inc. | 23 | $414 |
| Neos Therapeutics, LP | 40 | $407 |
| Otsuka America Pharmaceutical, Inc. | 11 | $325 |
| Alkermes, Inc. | 19 | $321 |
| Supernus Pharmaceuticals, Inc. | 20 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $285 |
| Almatica Pharma LLC | 16 | $260 |
| Ironshore Pharmaceuticals Inc. | 13 | $240 |
| Tris Pharma Inc | 9 | $238 |
| Lundbeck LLC | 14 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $187 |
| Axsome Therapeutics, Inc. | 7 | $142 |
| Neurocrine Biosciences, Inc. | 5 | $121 |
| Idorsia Pharmaceuticals US Inc | 6 | $108 |
| Johnson & Johnson | 4 | $94 |
| Jazz Pharmaceuticals Inc. | 3 | $68 |
| Sunovion Pharmaceuticals Inc. | 6 | $66 |
| Adlon Therapeutics L.p. | 4 | $63 |
| Neuronetics, Inc. | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Noven Therapeutics, LLC | 2 | $37 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$120
- REXULTI$118
- Dyanavel XR$107
- Quillichew ER$107
- Quillivant$107
How this compares
$5,457 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 20 | $459 |
| Duloxetine Hcl | 24 | $418 |
| Bupropion XlBupropion Hcl | 15 | $379 |
| Trazodone Hcl | 15 | $369 |
| Olanzapine | 21 | $306 |
| Hydroxyzine Hcl | 11 | $290 |
| Escitalopram Oxalate | 30 | $218 |
| Lorazepam | 16 | $203 |
| Propranolol Hcl | 12 | $202 |
| Fluoxetine Hcl | 17 | $165 |
| Risperidone | 17 | $163 |
| Lithium Carbonate | 19 | $7 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in New Lenox
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.